Catherine is a medical physicist with 8 years’ experience in MRI research, including pulse sequence programming, protocol optimisation, image post-processing, and image analysis. She has extensive experience in quantitative MRI (T1, T2 and multi-parametric mapping), fMRI methods, and techniques to measure brain perfusion (such as Arterial Spin Labelling) and blood flow. Catherine has experience with new methods in oncology such as Chemical Exchange Saturation Transfer (CEST) to study glucose metabolism and pH alterations, and Equilibrium-MRI. She has also studied a variety of techniques to measure iron deposition in the brain. Her current focus is on developing novel imaging methods to study Alzheimer’s disease and is part of a nationwide Brain Research New Zealand funded study of mild cognitive impairment and early Alzheimer’s. Catharine leads the Neuroimaging Research Group (NRG) at the University of Auckland.